Exoskeleton-Assisted Mobility in Aging and in Parkinson's Disease (NCT07567482) | Clinical Trial Compass
RecruitingNot Applicable
Exoskeleton-Assisted Mobility in Aging and in Parkinson's Disease
Canada26 participantsStarted 2026-04-30
Plain-language summary
This study will evaluate whether a wearable robotic exoskeleton can improve mobility, balance, and walking in healthy older adults and in individuals living with Parkinson's disease, populations at high risk of falls and mobility limitations. Participants will attend two laboratory sessions. The first session includes clinical assessments, fitting and familiarization with the exoskeleton, and interviews to explore user perceptions. The second session involves performing functional mobility tasks (e.g., walking, standing, turning) with and without the exoskeleton and under different assistance levels, while movement is measured using wearable sensors.
The study will assess the immediate effects of the exoskeleton on mobility, compare assistance levels, identify which participants benefit most, and explore user experience and acceptability. Findings will help inform the development and implementation of assistive technologies to support mobility in healthy aging and in individuals with Parkinson's disease.
Who can participate
Age range
50 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Participants with Parkinson's disease
Inclusion Criteria:
* Ability to walk for at least 30 minutes with or without minimal aid
* Diagnosis of idiopathic Parkinson's disease
* Hoehn and Yahr stage 1 to 4
Exclusion Criteria:
* Height smaller than 152 cm
* Severe vascular conditions of the lower limbs that may limit mobility or pose a risk.
* Presence of any implantable or external life-sustaining medical device such as a pacemaker
* Severe osteoporosis or high risk of fractures
* Contra-indication to the required physical effort
* Severe cognitive impairment (MoCA \< 21)
* Presence of neurological disorders, lower-limb injuries, or other conditions interfering with mobility, other than Parkinson's disease.
Healthy elderly participants without Parkinson's disease
Inclusion Criteria:
* Ability to walk for at least 30 minutes with or without minimal aid
* Age ≥ 65 years old
Exclusion Criteria:
* Height smaller than 152 cm
* Severe vascular conditions of the lower limbs that may limit mobility or pose a risk.
* Presence of any implantable or external life-sustaining medical device such as a pacemaker
* Severe osteoporosis or high risk of fractures
* Contra-indication to the required physical effort
* Severe cognitive impairment (MoCA \< 21)
* Presence of neurological disorders, lower-limb injuries, or other conditions interfering with mobility
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Changes in Timed Up and Go (TUG) duration
Timeframe: Through intervention completion, on average one hour
2
Changes in 10 meters walk test (10MWT) walking speed
Timeframe: Through intervention completion, on average one hour
3
Changes in 5 repetitions sit-to-stand test (5STS) duration
Timeframe: Through intervention completion, on average one hour
Trial details
NCT IDNCT07567482
SponsorCentre intégré de santé et de services sociaux de l'Outaouais